BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14624907)

  • 1. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.
    Boon H; Westlake K; Stewart M; Gray R; Fleshner N; Gavin A; Brown JB; Goel V
    Urology; 2003 Nov; 62(5):849-53. PubMed ID: 14624907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
    Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
    Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent use of complementary medicine by prostate cancer patients.
    Ponholzer A; Struhal G; Madersbacher S
    Eur Urol; 2003 Jun; 43(6):604-8. PubMed ID: 12767359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions.
    Boon H; Stewart M; Kennard MA; Gray R; Sawka C; Brown JB; McWilliam C; Gavin A; Baron RA; Aaron D; Haines-Kamka T
    J Clin Oncol; 2000 Jul; 18(13):2515-21. PubMed ID: 10893281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.
    Chan JM; Elkin EP; Silva SJ; Broering JM; Latini DM; Carroll PR
    Urology; 2005 Dec; 66(6):1223-8. PubMed ID: 16360447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
    Singh H; Maskarinec G; Shumay DM
    Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.
    Beebe-Dimmer JL; Wood DP; Gruber SB; Douglas JA; Bonner JD; Mohai C; Zuhlke KA; Shepherd C; Cooney KA
    Urology; 2004 Feb; 63(2):282-7. PubMed ID: 14972472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we prevent prostate cancer?
    Chong P; Rashid P
    Aust Fam Physician; 2005 Apr; 34(4):265-7. PubMed ID: 15861749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Men with prostate cancer: making decisions about complementary/alternative medicine.
    Boon H; Brown JB; Gavin A; Westlake K
    Med Decis Making; 2003; 23(6):471-9. PubMed ID: 14672107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary and alternative medicine utilization by a sample of infertile couples in Jordan for infertility treatment: clinics-based survey.
    Bardaweel SK; Shehadeh M; Suaifan GA; Kilani MV
    BMC Complement Altern Med; 2013 Feb; 13():35. PubMed ID: 23414246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan.
    Yoshimura K; Ichioka K; Terada N; Terai A; Arai Y
    Int J Clin Oncol; 2003 Feb; 8(1):26-30. PubMed ID: 12601539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary and alternative medicine (CAM) in prostate and bladder cancer.
    Philippou Y; Hadjipavlou M; Khan S; Rane A
    BJU Int; 2013 Dec; 112(8):1073-9. PubMed ID: 23944379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and alternative therapies for advanced prostate cancer.
    Smith MR
    Hematol Oncol Clin North Am; 2001 Jun; 15(3):559-71. PubMed ID: 11525297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer.
    Zuniga KB; Zhao S; Kenfield SA; Cedars B; Cowan JE; Van Blarigan EL; Broering JM; Carroll PR; Chan JM
    J Urol; 2019 Oct; 202(4):689-695. PubMed ID: 31091175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of complementary medicine in urologic practice. A review of recent studies with emphasis on use among prostate cancer patients.
    Zimmerman RA; Thompson IM
    Urol Clin North Am; 2002 Feb; 29(1):1-9, vii. PubMed ID: 12109336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of complementary and alternative medicine among men with prostate cancer in a rural setting.
    Butler S; Owen-Smith A; DiIorio C; Goodman M; Liff J; Steenland K
    J Community Health; 2011 Dec; 36(6):1004-10. PubMed ID: 21499937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and correlates of complementary and alternative medicine use among cancer patients in usmanu danfodiyo university teaching hospital, Sokoto, Nigeria.
    Aliyu UM; Awosan KJ; Oche MO; Taiwo AO; Jimoh AO; Okuofo EC
    Niger J Clin Pract; 2017 Dec; 20(12):1576-1583. PubMed ID: 29378990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.
    Diefenbach MA; Hamrick N; Uzzo R; Pollack A; Horwitz E; Greenberg R; Engstrom PF
    J Urol; 2003 Jul; 170(1):166-9. PubMed ID: 12796672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The supportive care needs of men with prostate cancer (2000).
    Steginga SK; Occhipinti S; Dunn J; Gardiner RA; Heathcote P; Yaxley J
    Psychooncology; 2001; 10(1):66-75. PubMed ID: 11180578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes and use of complementary medicine in men with prostate cancer.
    Wilkinson S; Gomella LG; Smith JA; Brawer MK; Dawson NA; Wajsman Z; Dai L; Chodak GW
    J Urol; 2002 Dec; 168(6):2505-9. PubMed ID: 12441950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.